» Articles » PMID: 39518592

Frequencies or Absolute Numbers? Cluster Analysis of Frequencies and Absolute Numbers of B-Cell Subsets in Dialysis Patients Who Are Candidates for Kidney Transplantation Reveals Different Profiles

Abstract

Detailed characterization of B cells in dialysis patients who are candidates for kidney transplant is still lacking, with little information on how dialysis duration and modality impact B cell subsets. Cluster analysis of flow cytometry determined the frequencies and absolute numbers of B-cell subsets and divided the cohort of 78 candidates into two distinct clusters, one with shorter and one with longer dialysis duration. The immune profiles of the clusters differed depending on whether frequencies or absolute counts were considered. In long-term dialysis patients, the frequency of total memory, double negative and marginal zone B cells increased, while the frequency of naive and regulatory B cells decreased. This pattern was reversed in short-term dialysis patients, with a decrease in memory and an increase in naive and regulatory populations. The B subset number decreased significantly in long-term dialysis patients, while it increased significantly in short-term dialysis patients. The dialysis modality affected the frequency-based subset immune profiles. It is important to determine whether the evaluation is based on frequencies or absolute numbers. The different distribution of B cell subsets in the clusters, in terms of frequencies and absolute numbers, was influenced by dialysis duration. Modality and age only influenced the frequencies.

References
1.
Franzin R, Stasi A, Caggiano G, Squiccimarro E, Losappio V, Fiorentino M . Enhancing Immune Protection in Hemodialysis Patients: Role of the Polymethyl Methacrylate Membrane. Blood Purif. 2023; 52 Suppl 1:49-61. PMC: 10210079. DOI: 10.1159/000529971. View

2.
Streitz M, Miloud T, Kapinsky M, Reed M, Magari R, Geissler E . Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study. Transplant Res. 2013; 2(1):17. PMC: 3827923. DOI: 10.1186/2047-1440-2-17. View

3.
Kim K, Chung B, Jeon E, Kim B, Choi B, Park C . B cell-associated immune profiles in patients with end-stage renal disease (ESRD). Exp Mol Med. 2012; 44(8):465-72. PMC: 3429810. DOI: 10.3858/emm.2012.44.8.053. View

4.
Burton H, Perisanidou L, Steenkamp R, Evans R, Mumford L, Evans K . Causes of renal allograft failure in the UK: trends in UK Renal Registry and National Health Service Blood and Transplant data from 2000 to 2013. Nephrol Dial Transplant. 2018; 34(2):355-364. DOI: 10.1093/ndt/gfy168. View

5.
Crepin T, Gaiffe E, Courivaud C, Roubiou C, Laheurte C, Moulin B . Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections. Transpl Infect Dis. 2016; 18(3):415-22. DOI: 10.1111/tid.12534. View